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Objective: Totally percutaneous aortic aneurysm repair has been shown to be technically feasible, with low morbidity.
Complications from percutaneous arterial closure are not insignificant, however, and can be fatal. We sought to evaluate
our experience with this technique, compare it with the published literature, and identify factors associated with
conversion to open repair and complications.
Methods: A retrospective review of a prospectively collected database was performed. All patients who underwent
percutaneous closure of large-bore-sheath (>12F) access sites with off-label use of a suture-mediated closure device
(Prostar XL) between December 2002 and August 2005 were reviewed. Outcome measures evaluated were rates of
technical success, conversion to open femoral arterial repair, and complications. Axial diameter measurements of the
accessed vessels were assessed with computed tomographic (CT) angiography both before and after the procedure. Patient
variables were compared by using 2, Fisher exact, and paired and independent samples t tests where appropriate. The
mean follow-up interval was 1.5 years.
Results: During the study period, 49 patients underwent percutaneous closure of 79 large-bore-sheath access sites after
successful endovascular aneurysm repair. Seven patients (14%) were morbidly obese (body mass index >35 kg/m2).
Successful closure was achieved in 74 access sites (93.7%). Percutaneous closure was unsuccessful in five access sites (6.3%),
all of which required open femoral repair at the same setting. Two converted patients experienced complications (4.1%):
one retroperitoneal hematoma requiring transfusion of blood products and one iliac artery injury leading to death from
myocardial infarction. Both of these patients were morbidly obese. Both complications occurred after closure of larger
than 20F sheath sites. Morbid obesity and sheath size greater than 20F were associated with a significantly increased
complication rate (P  .02 and P  .01, respectively). No thrombotic or infectious complications occurred in this series.
Upon comparison of preoperative and postoperative CT angiograms, one (1.3%) small pseudoaneurysmwas detected. No
arteriovenous fistulas or hematomas larger than 3 cm were detected. The pseudoaneurysm occurred after closure of a 20F
sheath access site. There were no significant differences in minimum intraluminal (7.38 1.8 vs 7.48 1.8) or maximum
extraluminal (11.25  2.8 vs 12.02  2.7) diameters between preoperative and postoperative CT angiograms,
respectively.
Conclusions:Totally percutaneous aortic aneurysm repair is technically feasible in most cases, with no effect on the luminal
diameter of the accessed femoral artery. Complications occur more often in morbidly obese patients and with sheaths
larger than 20F. These complications can be minimized with meticulous technique and good patient selection. The
capability for expeditious open femoral arterial repair is mandatory with this approach. (J Vasc Surg 2006;43:270-6.)Endovascular therapy for the treatment of aortic pathol-
ogy has become standard in many institutions. The preclose
technique was initially described in detail in 1999 by Haas et
al1 for totally percutaneous closure of femoral arteriotomies
after intervention with large-bore sheaths. This technique was
then expanded for use in the totally percutaneous approach
for repair of infrarenal aortic aneurysms with endoluminal
stent grafts. High rates of technical success and relatively low
morbidity rates have been reported1-11 (Table I). Currently,
From the Departments of Surgerya and Radiology,b Madigan ArmyMedical
Center.
Competition of interest: no outside financial support or provision of supplies
was solicited or received in connection with this work. Dr Starnes was
under contract with Abbott Vascular on one occasion (September 2005)
in the capacity as faculty member and instructor for the training of newly
hired product specialists. The authors have no commercial or proprietary
interest in any private firm, special interest, drug, device, or equipment.
Reprint requests: Benjamin Ware Starnes, MD, FACS, Department of
Surgery, Vascular and Endovascular Surgery Service, Madigan Army
Medical Center, 9040-A Fitzsimmons Ave, Tacoma, WA 98431-1100
(e-mail: bwtarnes@comcast.net).
0741-5214/$32.00
Copyright © 2006 by The Society for Vascular Surgery.
doi:10.1016/j.jvs.2005.11.004
270however, few reports describe factors that are predictive of
complications or conversion to open femoral arterial repair.
We sought to evaluate our own experience with this tech-
nique, to compare it with the published literature, and to
identify factors associated with conversion to open femoral
arterial repair and complications.
METHODS
A single-institution retrospective review of a prospectively
collected database was performed. All patients who under-
went percutaneous closure of large-bore-sheath (12F) ac-
cess sites with off-label use of a suture-mediated closure device
(Prostar XL; Abbott, Menlo Park, Calif) between December
2002 and August 2005 were reviewed. Demographic data
were recorded, as were multiple intraoperative variables,
including estimated blood loss, total contrast used, and
systolic blood pressure at the time of sheath removal.
Outcome measures evaluated were rates of technical suc-
cess, conversion to open femoral arterial repair, and inci-
dence of complications. Most patients underwent preoper-
ative and postoperative computed tomographic (CT)
angiography according to institutional protocol before and
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mm. Patients with underlying renal insufficiency (creati-
nine 2.0 mg/dL) were followed up with postoperative
duplex ultrasonography. All CT angiograms extended well
below the femoral heads to allow for evaluation of both
common femoral arteries (CFAs). Axial diameter measure-
ments of the accessed vessels were assessed with CT angiog-
raphy both before and after the procedure by one of two
independent radiologists and recorded. Vessel measure-
ments were made throughout the entire CFA, and the mini-
mum intraluminal diameter was recorded as the smallest-
diameter lumen from inner arterial wall to inner arterial
wall. The maximum extraluminal diameter was recorded as
the largest outer wall to outer wall diameter throughout the
entire CFA. The presence of an arteriovenous fistula, pseu-
doaneurysm, or hematoma larger than 3 cm not present on
preoperative imaging was defined as significant. The stan-
dard follow-up consisted of protocol CT angiography
within 2 weeks of repair and often before discharge the day
after surgery. Patients then were re-evaluated at 1 year if the
absence of endoleak was proven by CT. Patients with type
II endoleaks were followed up at 6-month intervals and
treated as appropriate.
All procedures were performed in an operating room.
General and regional anesthetic techniques were used. Ankle-
brachial indices were not routinely obtained in all patients
and were thus excluded from this data set. Most patients
were assessed by clinical examination alone in the setting of
palpable pedal pulses. Technical success was defined as a
successful arterial closure without the need for surgical
cut-down and no change in baseline pulse examination.
Complications were defined as related directly to the access
procedure and were divided into major and minor compli-
cations. Major complications required medical or surgical
intervention for correction. Major complications related to
percutaneous access included hemorrhage requiring trans-
fusion, arterial thrombosis, distal embolization, arterial in-
fection, hematoma requiring evacuation, and hemorrhagic
complication resulting in stroke, myocardial infarction, or
Table I. Literature review depicting author, numbers of p






Starnes* 2005 49 79 2 (4
Quinn6 2004 63 100 8 (1
Morasch5 2004 47 94 2 (4
Torsello11 2003 15 27 1 (6
Krajcer3 2002 30 60 0 (0
Rachel7 2002 62 100 3 (4
Teh9 2001 44 82 2 (4
Howell2 2001 144 144 0 (0
Traul14 2000 17 29 0 (0
Haas1 1999 12 13 0 (0
Total 483 728 18 (3
*Current series.death. Minor complications related to percutaneous accesswere defined as a deviation from the expected outcome that
did not require surgical intervention. Minor complications
included small pseudoaneurysms or arteriovenous fistulas
requiring observation alone, cellulitis, and hematoma
smaller than 3 cm.
Data analysis. Data are expressed as mean  SEM.
Patient variables were compared by using 2, Fisher exact,
and paired and independent samples t tests where appro-
priate. Significance was set at P  .05 and reflected two-
tailed distributions in all cases. Each access site was used as
its own independent binomial categorical variable relating
to the success or failure of percutaneous closure. Compli-
cations are reported per patient and not per access site. The
mean follow-up interval was 1.5 years. Statistical analysis
was performed with SPSS software (SPSS Windows 11.0;
SPSS Inc, Chicago, Ill).
Patient selection. Early in our series, 15 patients un-
derwent closure of a contralateral access site only by using a
totally percutaneous technique. As our experience broad-
ened, both ipsilateral and contralateral access sites were
considered for this technique, and to date, our last 34
consecutive patients were approached with a totally percu-
taneous technique. Our current policy is to offer totally
percutaneous aneurysm repair to all patients who present
for elective endovascular aneurysm repair (EVAR) in the
absence of severe occlusive or aneurysmal disease of the
CFAs. It has been our experience to date that most patients
with severe atherosclerotic disease in the CFAs also have
extensive disease in the external iliac arteries that excludes
them from meeting standard criteria for EVAR (7-mm
access vessels for the Zenith Cook graft; Cook, Blooming-
ton, Ind). A requirement for simultaneous repair of the
CFA, ie, aneurysmal disease, eliminates the utility of a
totally percutaneous approach.
The preclose technique. The preclose technique for
closure of large-bore arterial access sheath sites has been
described previously in a few publications with a varying
degree of modification, depending on the author.1-4,6-14






5 (6.3%) 74 (94%) 16.1 (12-24)
) 0 (0%) 96 (96%) 13.6 (12-18)
7 (7.4%) 87 (93%) 15 (12-18)
1 (3.7%) 25 (93%) 19 (14-25)
2 (3.3%) 58 (97%) 19 (16-22)
24 (24%) 76 (76%) 18.7 (16-22)
12 (14.6%) 70 (85%) 18.5 (16-22)
8 (5.6%) 136 (94%) 16 (16)
10 (35%) 19 (66%) 19.2 (16-24)
0 (0%) 13 (100%) 15.5 (12-22)












.7%)Our technique is described in detail below.
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ered from the preoperative CT scan to include diameter
measurements, degree of calcification, and level of the
femoral bifurcation related to the femoral head on each
side. In the operating room, the patient is prepared and
draped either awake under locoregional anesthesia or asleep
under general anesthesia. Antiseptic plastic drapes are rou-
tinely used to prevent contact of sutures directly with the
skin. Patients who are morbidly obese (body mass index
35 kg/m2) or are deemed to have issues related to
complicated access undergo ultrasound-guided access by
using a micropuncture technique to ensure precise entry
into the anterior wall of the CFA. A small stab incision is
made inferior to the expected arterial puncture site, and
blunt dissection is carried down through the Scarpa fascia
with a tonsil clamp. In thin patients, this distance is very
short, whereas in obese patients, this distance may be
greater to allow for smooth passage of large-bore sheaths at
a less acute angle. A single-wall needle puncture is used to
gain access to the CFA with a modified Seldinger tech-
nique. A 6F short sheath is then placed over a wire into the
artery and flushed. Contrast arteriography is used at an
oblique projection to confirm access directly within the
CFA: ie, between the inferior epigastric artery and femoral
bifurcation. The 6F sheath is then replaced with a single
10F Prostar XL suture-mediated closure device over the
wire, and the wire is then removed.
The Prostar XL device consists of four components: (1)
a hydrophilic catheter that accepts a standard 0.035-inch
wire to guide the device into the aorta; (2) a marker lumen
that is contiguous with a marker tube and allows documen-
tation of proper positioning within the artery, as evidenced
by pulsatile blood flow from the marker lumen, commonly
referred to as mark; (3) a rotating barrel that serves two
functions: to dissect bluntly and atraumatically down to the
artery in a rotating fashion and to capture four nitinol
needles when locked into appropriate position; and (4) a
needle-delivery system that consists of a handle coaxially
attached to four needles that, when turned counterclock-
wise and withdrawn, delivers the four needles and two
braided sutures through the arterial wall and into the
rotating barrel. After needle deployment, slack is removed
from the suture in the direction of needle access, and the
sutures are then laid out in a radial fashion and secured to
the sterile drapes by using shodded clamps. One suture is
white, and one is green. The white suture always deploys in
a 2- and 8-o’clock position, and the green suture always
deploys in a 10- and 4-o’clock position. It is important to
avoid crossing the sutures. A wire is then replaced through
the device and into the aorta. Standard EVAR then ensues
with dilation of the arteriotomy up to 24F internal diameter
(27F outer diameter). At the completion of the operation,
the sutures are secured and heavily irrigated with heparin-
ized saline. It is critical that the white suture be tied first,
because it lies in a more anterior location within the artery
than the green. Because the sutures are in a crossing pat-
tern, tying the deeper green suture first may actually entrap
the white suture and prevent knot slippage and a successfulclosure. A modified fisherman’s knot is used to glide the
suture down to the level of the artery. The sheath should
always be removed over a hydrophilic wire to maintain
access to the artery should the closure fail. This allows for
temporary balloon or dilator occlusion and a controlled
femoral artery exposure for direct repair of the artery.
During sheath removal, liberal pressure is applied to the
distal external iliac artery above the inguinal ligament. This
can prove difficult in morbidly obese patients but is made
easier with the routine use of general anesthesia and an
additional assistant to retract the pannus. The sheath is
gently removed by an assistant, and only upon complete
removal is the first knot on the white suture cinched down
with a knot pusher. Cinching the suture around the sheath
during withdrawal may cause the sheath to become locked
in the artery. This is especially common with nonbraided
sheaths because of kinking of the sheath. The second knot
is tied down in exactly the same fashion with a knot pusher,
and an assessment is made of effective hemostasis after
removal of manual compression. If an adequate result is
achieved, the wire is slowly withdrawn, and the knots are
cinched down one last time. A special knot pusher and
cutting tool is then advanced down each rail of the suture,
and the sutures are cut well beneath the surface of the skin.
Protamine sulfate is administered at a dose of only 0.25 to
0.75 mg/100 U of heparin according to the time from
initial heparinization and only after the sheaths have been
removed. Manual pressure is most often not needed at all,
but if required, it is applied until complete hemostasis is
achieved. This has not been longer than 10 minutes in any
case. The wounds are flushed out with irrigation, and a
single deep dermal stitch is used to close the wound. The
patient remains flat for 1 hour in the recovery room.
Access too high in the groin can actually cause the
inguinal ligament to become incorporated into the closure
like a pledget sewn directly onto the artery.12 Upon move-
ment of the patient, the suture may tear through the artery
and result in a bleeding complication. This is usually rec-
ognized upon passage of the 6F sheath, which demon-
strates some resistance to insertion. Access too low in the
groin can cause an arteriotomy in the deep or superficial
femoral artery that may then lead to vessel thrombosis,
pseudoaneurysm, or arteriovenous fistula formation. We
have adopted a policy of removing the larger of the two
sheaths first to allow for continued access from the smaller
sheath should angiographic assessment of the larger access
site or rapid control of the aorta be required.
RESULTS
During the study period, 49 patients underwent percu-
taneous closure of 79 large sheath access sites after success-
ful EVAR. All procedures were performed in an operating
room. General, regional, and local anesthetic techniques
were used in 27 (55.1%), 20 (40.8%), and 2 (4.1%) patients,
respectively. One patient underwent successful totally per-
cutaneous repair of a ruptured infrarenal aneurysm under
local anesthesia. Two patients underwent endovascular re-
pair of descending thoracic aortic aneurysms. Most en-
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Bloomington, Ind). Successful percutaneous closure was
achieved in 74 (93.7%) of 79 accessed sites.
Patient characteristics are listed in Table II. The mean
age was 74.2 years (range, 56.6-89.6 years). The mean
aneurysm size was 5.82  1.07 cm (range, 3.9-9.0 cm). A
single patient with a 3.9-cm infrarenal aneurysm was
treated for a coexistent 4-cm iliac aneurysm. Seven patients
(14%) weremorbidly obese (bodymass index35 kg/m2).
Intraoperative variables and length of hospital stay are listed
in Table III. Percutaneous closure was unsuccessful in five
access sites (6.3%), all of which required open femoral
arterial repair at the same setting. No patient undergoing
conversion to an open repair required a change in anes-
thetic technique. One patient required conversion be-
cause of a technical error in sheath removal and one
because of closure device failure, and another patient was
converted at the surgeon’s discretion because of inade-
quate mark. The two (4.1%) remaining converted pa-
tients experienced hemorrhagic complications: one ret-
roperitoneal hematoma that necessitated transfusion of
blood products and one iliac artery injury that led to
death from myocardial infarction. Both of these patients
were morbidly obese. Both complications occurred after
Table II. Characteristics of 49 patients undergoing
percutaneous access and closure
Patient demographics n %
Male sex 45 90%
Hypertension 44 88%
Tobacco use 43 86%
Hyperlipidemia 42 84%
Calcium in femoral arteries (per site by CT) 60 75%
Antiplatelet before surgery 27 55%
Coronary artery disease 24 48%
Prior MI 17 34%
COPD 14 28%
Diabetes 12 24%
Warfarin before surgery 9 18%
Congestive heart failure 8 16%
Morbid obesity (BMI 35 kg/m2) 7 14%
Chronic renal insufficiency (Cr 1.5 mg/dL) 6 12%
CT, Computed tomography; MI, myocardial infarction; COPD, chronic
obstructive pulmonary disease; BMI, body mass index; Cr, creatinine.
Table III. Intraoperative variables and hospital length of
stay for the study group
Variable Mean  SD Range
SBP at time of closure (mm Hg) 135  19 99-198
Operative time (min) 160  65 61-375
Contrast volume (mL) 79.5  35.9 35-210
EBL (mL) 155  293 20-2500
PRBCs transfused (U) 0.15  0.53 0-4
Length of stay (h) 62  61 12-362
SBP, Systolic blood pressure; EBL, estimated blood loss; PRBCs, packed red
blood cells.closure of 20F sheath sites. Both major complicationsoccurred in patients who were under general anesthesia,
and in one of these patients, the failure of the totally
percutaneous approach was recognized in the recovery
room. The patient had to be returned to the operating
room and was reintubated. Morbid obesity and sheath
size of 20F or larger were associated with a significant
increase in the complication rate (P  .02 and P  .01,
respectively; Table IV). Morbid obesity was not associ-
ated with a significant increase in the rate of conversion
to open repair (P .14). Sheath size of 20F or larger was
significantly associated with an increased rate of conver-
sion to open repair (P  .01; Table V). There were no
thrombotic or infectious complications in this series.
Upon comparison of preoperative and postoperative CT
angiograms, there was one (1.3%) small 6-mm pseudo-
aneurysm (Fig 1), and no arteriovenous fistula or hema-
toma larger than 3 cm was detected. There were no
significant differences in minimum intraluminal (7.38 
1.8 vs 7.48  1.8) or maximum extraluminal (11.25 
2.8 vs 12.02  2.7) diameters between preoperative and
postoperative CT angiograms, respectively (Fig 2).
Calcified plaque was evident in the CFAs of 75% of the
study population by noncontrasted CT. Posterior calcifica-
tion only was noted in 61%, whereas circumferential calci-
fication was noted in 14%. The presence of calcified plaque
within the CFA, whether circumferential or posterior, was
not significantly associated with an increased rate of con-
version (P .96) or complications (P .29; equal variance
was not assumed).
DISCUSSION
There are currently no large multicenter randomized,
controlled trials comparing standard open femoral artery
Table IV. Morbid obesity and sheath size versus
conversion to open femoral repair and complications
Variable Odds ratio P value
Morbid obesity vs conversion 4.8 .14
Sheath size 20F vs conversion 17.1 .01
Morbid obesity vs complication 14.8 .02
Sheath size 20F vs complication  .01
Table V. Success rate based on sheath size for 79
access sites
Sheath size (F) n Success (n/%)
24 1 1 (100%)
22 1 0 (0%)
20 16 13 (81%)
18 18 18 (100%)
16 7 7 (100%)
14 21 21 (100%)
12 14 14 (100%)
20 18 14 (78%) (P .04)
18 61 60 (98.4%)exposure and repair with percutaneous arterial closure in
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nique are from single institutions and small patient series.
This trend will likely not continue as more operators be-
come familiar with a totally percutaneous technique and
advances in stent graft design allow delivery systems to
decrease in size. Totally percutaneous aneurysm repair re-
quires good patient selection, technical expertise, and a
thorough understanding of troubleshooting techniques for
the device.
Complications associated with open femoral arterial
exposure and repair for EVAR can be significant. In a
mid-term analysis of EVAR in 186 patients, Dalainas et al15
noted an 8% wound infection rate, a 6.5% rate of local
wound complications, including wound necrosis and dehis-
cence, and a 4.8% rate of lymphocele formation. Torsello
et al11 conducted the first prospective, randomized com-
parison of open femoral artery repair vs percutaneous clo-
sure by using the preclose technique. Although this was a
small series with only 30 patients, the authors found a 20%
incidence (3/15) of lymphoceles in the open group vs none
in the percutaneous group. A small, single-institution, con-
trolled retrospective review by Morasch et al5 demon-
strated a 22.8% incidence of complications in the open
repair group vs none in the percutaneous group after a
30-day follow-up. Complications included three lympho-
celes, three femoral neuropathies, one groin infection, and
one case of persistent scrotal edema. All early complications
from the percutaneous group were recognized during sur-
gery and remedied at the time, and none of these patients
had a complication at 30 days.
Several investigators have identified risk factors associ-
Fig 1. Small 6-mm left-sided pseudoaneurysm after totally per-
cutaneous repair with a 20F sheath. This patient had a high left
femoral bifurcation and underwent high access by using an ultra-
sound-guided micropuncture technique.ated with a totally percutaneous technique for EVAR.Morbid obesity has been identified in more than one series
as a predisposing risk factor for poor outcome associated
with totally percutaneous aneurysm repair.2,7,9,12 Teh
et al9 found that 42% of closure failures (5 of 12 failed sites)
were attributable to morbid obesity: this led to a fatal
outcome in 1 patient. Our series demonstrates a significant
association between morbid obesity and the incidence of
both conversion to open repair and complications. Ironi-
cally, this subset of patients is at highest risk and yet seems
to have the most potential to benefit from this technique.
Our only fatality was a morbidly obese elderly female
patient undergoing endovascular repair of a descending
thoracic aneurysm with a 22F sheath who required a sheath
exchange through the same access site. In this case, a
hypotensive episode occurred during sheath exchange that
prompted a search for iliac injury before percutaneous
closure. No injury was found on subsequent contrast injec-
tions, and closure was attempted. The patient became
profoundly hypotensive, and despite rapid aortic control
with an occlusion balloon from the contralateral sheath, she
experienced a fatal myocardial infarction. This case illus-
trates the significance of the underlying comorbidities and
limited physiologic reserve of morbidly obese patients. The
arterial injury in the distal external iliac artery may have
been easily recognized with an open exposure. A lower
threshold for open conversion and a higher index of suspi-
cion should be maintained in this subset of patients. Main-
tenance of wire access until hemodynamic stability can be
assured seems prudent in the morbidly obese.
A large sheath size also contributes to morbidity, not
only in conjunction with EVAR, but also in standard diag-
nostic and interventional procedures throughout the West-
ern world. Börner et al16 recently described their experi-
ence with a totally percutaneous technique for EVAR and
listed sheath size as a predictor for an increased rate of
conversion to open repair and complications. Twenty per-
cent of patients with a sheath size of 20F did not undergo
successful closure. It is interesting to note that each of their
patients underwent application of an external compression
device (FemoStop II Plus; Radi Medical Systems AB, Upp-
sala, Sweden) for 2 hours after percutaneous closure. In this
setting, it is difficult to discern which device was being
validated: the Prostar XL or the FemoStop II Plus. In the
current series, sheath size was associated with a significant
increase in conversion to open repair and complications.
Most of our conversions and complications occurred with
sheath sizes of 20F or greater. Eighteen of 79 access sites
received sheaths that were 20F or larger. Four (22.2%) of
these 18 patients were converted to open repair, consistent
with the recent data from Börner et al. Of the 61 remaining
sites, only 1 conversion to open repair occurred, represent-
ing a conversion rate of 1.6% for sheath sizes of 18F or less.
This conversion occurred early in our experience with a
device that failed to provide adequate mark. At the sur-
geon’s discretion, a cut-down was performed. Severe oc-
clusive disease was noted in the CFA at the access site.
Clearly, sheath size plays an important role in predicting
success or failure. A luminal diameter of less than 10F or 3.3
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approach. As device platform size decreases with advances
in catheter-based technology, this issue will become negli-
gible.
“Fluoroscopically visible calcification” is listed as a con-
traindication for use of the Prostar XL device in the manu-
facturer’s package insert. In the Cleveland Clinic experi-
ence, three of eight percutaneous closure failures were
attributable to heavily calcified vessels.14 In 2002, the
current author demonstrated in a prospective, randomized
trial that the presence of calcified plaque, documented by
duplex ultrasonography, was not associated with a signifi-
cant increase in complications associated with the 6F Techstar
and the mechanically similar 8F and 10F Prostar devices.13 It
is widely known that conventional CT is more sensitive for
detecting the presence of calcified plaque within arteries
than simple fluoroscopy alone. In the current series, 75% of
patients had evidence of a calcified plaque within the CFA
on CT angiography. Nearly 14% of all access sites had
evidence of circumferential calcified plaque on axial imag-
ing. Only 1 of 11 sites with circumferential calcification
required conversion to an open repair, and none of these
patients went on to develop a complication.We believe that
the presence of calcified plaque within the CFA on CT
angiography occurs in a large majority of patients with
aortic aneurysmal disease and that it should not exclude
these patients from an attempt at a totally percutaneous
technique. The presence of circumferential calcium should
elicit a lower threshold for conversion only if device deploy-
ment becomes complicated.
Technical expertise and a mastery of the Prostar device
are essential for successful outcomes. Contrast-enhanced
and noncontrast preoperative imaging should be thor-
oughly reviewed by the primary surgeon before a totally
Fig 2. Axial slices through the same patient in the region
totally percutaneous aneurysm repair. White arrows d
consistent with the postoperative appearance of the site. N
common femoral arteries.percutaneous technique is chosen for EVAR. Note shouldbe made of the quality and caliber of the access vessels,
including calcification, location of the femoral bifurcation
in respect to the femoral head, patency of the proximal
superficial femoral artery, and tortuosity/calcification of
the iliac vessels. Access to the anterior wall of the CFA only
is absolutely critical for a successful closure. Precise device
deployment and knowledge of troubleshooting techniques
promote a higher level of success with experienced opera-
tors. The device is not perfect, and mechanical failures do
occur. An understanding of how to remedy failed device
deployment is essential. Closure over a hydrophilic wire
should always be performed, and wire access should be
maintained for a longer period of time (until hemodynamic
stability can be confirmed) in morbidly obese patients.
One morbidly obese patient in our series who initially
had a successful closure experienced hypotension, tachycar-
dia, and ipsilateral groin hematoma in the recovery room
upon arrival. He was immediately returned to the operating
room and underwent open femoral artery exposure and
repair. He was found to have a large retroperitoneal hema-
toma and required transfusion of blood products. The ingui-
nal ligament had been incorporated into the closure and,
uponpatientmovement, tore the sutures through the anterior
arterial wall. The authors would like to re-emphasize the
importance of prudence in the practice of totally percutaneous
aneurysm repair. The capability for urgent femoral artery
exposure and repair is mandatory and cannot be disre-
garded. These procedures should be done with a vascular
surgeon as the principal operator or at least as a keymember
of the operating team and in close proximity to resources
facilitating an open surgical approach.
A thorough review of existing literature on totally
percutaneous repair of large-bore sheath access sites (Table
I) reveals 483 patients who underwent repair of 728 access
e common femoral arteries both before (A) and after (B)
te a mild amount of subcutaneous air and stranding
the minimal anatomic derangement in the region of theof th
elinea
oticesites. The overall technical success approaches 90%, and
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Nearly 10% of patients will require conversion to open
femoral arterial repair, almost always at the same setting.
Late complications are rare. Traul et al14 reported the
highest conversion rate with this technique. A closer look at
their data reveals a 38.5% failure rate with sheaths larger
than 20F. The mean sheath size for this group was 22.6F,
and this re-emphasizes the fact that larger sheath sizes
(20F) are associated with higher failure rates.
Limitations of this study include its retrospective de-
sign, which lends bias to the data. The current series is
small, and this increases the likelihood of a type II statistical
error. As stated previously, a large, multicenter, prospec-
tive, randomized comparison is needed to validate the
aforementioned results. Although an innovative and attrac-
tive technique for totally percutaneous aneurysm repair, the
preclose technique should be approached with a certain
amount of caution and respect for potentially devastating
complications. The morbidly obese may stand to benefit
the most from this technique but are probably the patients
who should (at least initially) be avoided.
CONCLUSIONS
Totally percutaneous aortic aneurysm repair is techni-
cally feasible in most cases and has no effect on the diameter
of the accessed femoral artery. Complications occur more
often in morbidly obese patients and with sheaths 20F or
larger. In short, procedural success relates to the size of
both the sheath and the patient. Complications can be
minimized with a thorough review of adequate preopera-
tive imaging, technical expertise, and good patient selec-
tion. The capability for expeditious open femoral arterial
repair is mandatory with this approach.
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